A pilot study of diethyldithiocarbamate in patients with acquired immune deficiency syndrome (AIDS) and the AIDS-related complex

This publication has 22 references indexed in Scilit:

• AIDS: FROM IMMUNITY TO INFECTION TO AUTOIMMUNITY. A COMPREHENSIVE HYPOTHESIS OF THE PATHOGENESIS OF THE DISEASE
  AIDS Research, 1986
• IN-VITRO INHIBITION OF LAV/HTLV-III INFECTED LYMPHOCYTES BY DITHIOCARB AND INOSINE PRANOBEX
  The Lancet, 1985
• IMMUNOMODULATION WITH DIETHYLDITHIOCARBAMATE IN PATIENTS WITH AIDS-RELATED COMPLEX
  The Lancet, 1985
• Quantitation of beta 2-microglobulin and other immune characteristics in a prospective study of men at risk for acquired immune deficiency syndrome
  JAMA, 1984
• Impaired Production of Lymphokines and Immune (Gamma) Interferon in the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1984
• Acid-Labile Alpha Interferon
  New England Journal of Medicine, 1983
• Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1983
• The effects of sodium diethyldithiocarbamate, azathioprine, cyclophosphamide, or hydrocortisone acetate administered alone or in association for 4 weeks on the immune responses of mice
  Clinical Immunology and Immunopathology, 1980
• Thymus-like activities of sulphur derivatives on T-cell differentiation.
  The Journal of Experimental Medicine, 1977
• THE EFFECTS OF THE PROTRACTED ADMINISTRATION OF THE CHELATING AGENT, SODIUM DIETHYLDITHIOCARBAMATE (DITHIOCARB)
  The Lancet Healthy Longevity, 1967